Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?

References

• FletcherCPetoRThe natural history of chronic airflow obstructionBMJ19771607716451648871704
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEMurrayRPSmoking and lung function of Lung Health Study participants after 11 yearsAm J Respir Crit Care Med2002166567567912204864
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• CoteCGDoderllyLJCelliBRImpact of COPD exacerbations on patient-centered outcomesChest2007131369670417356082
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbations on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
   PubMed Web of Science ®Google Scholar
• HalpinDMGDecramerMCelliBRKestenSLiuDTashkinDPExacerbation frequency and course of COPDInt J Chron Obstruct Pulmon Dis2012765366123055714
   PubMed Web of Science ®Google Scholar
• KannerREAnthonisenNRConnetJEfor the Lung Health Study Research GroupLower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Results from the Lung Health StudyAm J Respir Crit Care Med2001164335836411500333
   PubMed Web of Science ®Google Scholar
• SilvermanEKExacerbations in chronic obstructive pulmonary disease Do they contribute to disease progression?Proc Am Thorac Soc20074858659018073387
   PubMedGoogle Scholar
• MakrisDMoschandreasJDamaniakiAExacerbations and lung function decline in COPD: new insights in current and ex-smokersRespir Med200710161305131217112715
   PubMed Web of Science ®Google Scholar
• RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management and prevention of chronic obstructive lung disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
   PubMed Web of Science ®Google Scholar
• Rodríguez-RoisinRTowards a consensus definition for COPD exacerbationsChest20001175 Suppl 2398S401S10843984
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPWHershfieldESHardingGKMNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTCOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• CharlsonMSzatrowskiTPPetersonJGoldJValidation of a combined comorbidity indexJ Clin Epidemiol19944711124512517722560
   PubMed Web of Science ®Google Scholar
• MahlerDWellsCEvaluation of clinical methods for rating dyspneaChest19889335805863342669
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardization of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• HankinsonJLOdencrantzJRFedanKBSpirometric reference values from a sample of the general U.S populationAm J Respir Crit Care Med199915911791879872837
   PubMed Web of Science ®Google Scholar
• LisboaCLeivaAPinochetRRepettoPBorzoneGDiazOValores de referencia de la capacidad inspiratoria en sujetos sanos no fumadores mayores de 50 añosArch Bronconeumol2007439485489 Spanish17919414
   PubMed Web of Science ®Google Scholar
• QuirkFHJonesPWBaveystockCMLittlejohnsPA self complete measure for chronic airflow limitation: the St George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
   PubMed Web of Science ®Google Scholar
• WilliamsJESinghSJSewellLGuyattGHMorganMDDevelopment of a self-reported chronic respiratory questionnaire (CRQ-SR)Thorax2001561295495911713359
   PubMed Web of Science ®Google Scholar
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesAmerican Thoracic Society Statement. Guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
   PubMed Web of Science ®Google Scholar
• TroostersTGosselinkSDecramerMSix minute walking distance in healthy elderly subjectsEur Respir J199914227027410515400
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoAfor the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• MiratvillesMFerrerMPontAEffect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 years follow up studyThorax200459538739515115864
   PubMed Web of Science ®Google Scholar
• SpencerSCalverleyPMABurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
   PubMed Web of Science ®Google Scholar
• CasanovaCCoteCGMarinJMThe six-minute walk distance: long term follow up in patients with COPDEur Respir J200729353554017107991
   PubMed Web of Science ®Google Scholar
• TantucciCModenaDLung function decline in COPDInt J Chron Obstruct Pulmon Dis20127959922371650
   PubMed Web of Science ®Google Scholar
• CasanovaCde TorresJPAguirre-JaimeAThe progression of chronic obstructive pulmonary disease is heterogeneous. The experience of the BODE cohortAm J Respir Crit Care Med201118491015102121836135
   PubMed Web of Science ®Google Scholar
• VestboJEdwardsLDScanlonPDfor the ECLIPSE InvestigatorsChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
   PubMed Web of Science ®Google Scholar
• NishimuraMMakitaHNagaiKfor the Hokkaido COPD Cohort Study InvestigatorsAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121851445222016444
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJMartínez-GarcíaMARomán SanchezPSalcedoENavarroMOchandoRSevere acute exacerbation and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar